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 يف الفــرة، يف أحــد خمتــرات الرعايــة الصحيــة الثالثيــةO139  والــاO1 تــردد عــزل أنــاط حساســية ضــات الكولــرا الــا
2012-1999 مــا بــن
 إروما خان، نجية كريم غانيش، نعيمة فسيح،سيام عرفان

 وقــد هدفــت هــذه الدراســة.O139  والــاO1  يف العقــد املــايض عــى أمهيــة ســاالت ضــات الكولــرا الــا-  عامليـ ًا-  لقــد ُســلط الضــوء:اخلالصــة
 فأجــري حتليــل اســتعادي لبيانــات عينــات الــراز. وأنــاط حساســيتها لألدويــة يف باكســتانO139  والــاO1 إىل تقييــم تكــرار عــزل الكولــرا الــا
 وق ِّيمــت،2012  إىل عــام1999  والتــي عُزلــت يف خمتــر إحــاالت وطنــي مــن عــامO139  والــاO1 التــي حــدث فيهــا نمــو لضــات الكولــرا الــا
 لقــد أنتجــت عينــات الــراز املقدَّ مــة خــال.مقاومتهــا لألمبيســيلني والترتاســيكلني والكلورامفينيكــول والكوتريموكســازول واألوفلوكساســن
 منهــا ضــات كولــرا6%  كان، ســالة مــن ســاالت ضمــة الكولــرا3668  عينــة مــا جمموعــه95800  والتــي بلــغ جمموعهــا2012-1999 األعــوام
 وأظهــرت بيانــات حساســية امليكروبــات.2003  وبلــغ ذروتــه يف عــام، ووجــد أن معــدل العــزل كان مرتفع ـ ًا يف فصــل الصيــف.O139  والO1 ال
 إنــه مــن الــروري القيــام. مــع بقائهــا حساســة لألوفلوكساســن،لألدويــة زيــادة يف مقاومــة هــذه الــذراري للكوتريموكســازول واألمبيســيلني
. مــن أجــل التنبــؤ باألوبئــة املســتقبلية وحتديــد التدابــر الالزمــة للحــد مــن املــرض،برتصــد نشــط لألنــاط املصليــة وحلساســيتها لألدويــة
ABSTRACT In the past decade the importance of non-O1 and non-O139 strains of Vibrio cholerae has been
highlighted globally. This study aimed to evaluate the frequency and antimicrobial susceptibility profile of
non-O1 and non-O139 V. cholerae in Pakistan. Data of stool specimens yielding growth of non-O1 and non-O139
V. cholerae isolated at a national referral laboratory from 1999 to 2012 were retrospectively analysed and evaluated
for resistance to ampicillin, tetracycline, chloramphenicol, co-trimoxazole and ofloxacin. A total of 95 800 stool
samples submitted over 1999–2012 yielded 3668 strains of V. cholerae, of which 6% were non-O1 and non-O139
V. cholerae. A high isolation rate was found in the summer season, with a peak in the year 2003. Antimicrobial
susceptibility data revealed increasing resistance to co-trimoxazole and ampicillin, but strains remained highly
susceptible to ofloxacin. Active surveillance of serotypes and antimicrobial susceptibility is essential to predict
future epidemics and define measures to curtail the disease.

Fréquence d’isolation et profil de sensibilité de Vibrio cholerae non-O1 et non-O139 dans un laboratoire de
soins de santé tertiaires, 1999-2012
RÉSUMÉ Au cours des dix dernières années, l’importance des souches de Vibrio cholerae non-O1 et non-O139 a été
mise en avant à l’échelle mondiale. La présente étude visait à évaluer la fréquence de l'isolation des souches de Vibrio
cholerae non-O1 et non-O139 et leur profil de sensibilité aux antimicrobiens au Pakistan. Les données d'échantillons
de selles ayant permis la croissance de V. cholerae non-O1 et non-O139 isolés dans un laboratoire national spécialisé
entre 1999 et 2012 ont été analysées et évaluées rétrospectivement pour leur résistance à l’ampicilline, la tétracycline, au
chloramphénicol, au co-trimoxazole et à l’ofloxacine. Au total, 95 800 échantillons de selles soumis entre 1999 et 2012
ont produit 3668 souches de V. cholerae, parmi lesquelles 6 % étaient des souches de V. cholerae non-O1 et non-O139.
Un taux d’isolation élevé a été observé au cours de l’été, avec un pic en 2003. Les données relatives à la sensibilité aux
antimicrobiens ont révélé une augmentation de la résistance au co-trimoxazole et à l’ampicilline, mais les souches
restaient fortement sensibles à l’ofloxacine. Une surveillance active des sérotypes et de la sensibilité aux antimicrobiens
est essentielle pour prévenir les épidémies et définir des mesures permettant d'enrayer la maladie.
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Introduction
Food- and water-borne illnesses are
leading public health problems around
the world. Although in developed countries the predominant bacterial causes
of diarrhoea include pathogens such as
Salmonella and Campylobacter spp. (1),
in developing countries Vibrio cholerae
still remains the top cause of watery diarrhoea (2). V. cholerae is classified to
over 200 serotypes on the basis of variations in the lipopolysaccharide somatic
antigen (3). V. cholerae belonging to
serogroups O1 and O139 has been
associated with epidemics and pandemics of cholera due to production of
cholera toxin (2–5). Other serotypes
are collectively known as non-O1 and
non-O139 or non-typeable V. cholerae.
A majority of these strains are usually
responsible for sporadic cases of diarrhoea (6–8). However, the pathogenic
potential of non-O1 and non-O139 V.
cholerae should not be underestimated
as some strains are clearly pathogenic,
due either to cholera toxin production
or to other virulence factors such as
heat-stable enterotoxin, haemolysin,
repeats-in-toxin and type 3 secretion
systems (7). Occasionally, these strains
are responsible for outbreaks of cholera (9–11). According to the United
States Centers for Disease Control and
Prevention (CDC), non-O1 and nonO139 V. cholerae are the third most
commonly reported group of Vibrio
spp., and since the year 2000 they accounted for around 40 cases of diarrhoea per year reported to the CDC
(12). Moreover, in immunocompromised people these bacteria have been
associated with a severe form of disease
that may lead to sepsis and other lifethreatening conditions (13–15). The
susceptibility pattern of these reported
isolates are diverse, showing a varying
prevalence of different serovars in different regions.
In Pakistan V. cholerae O1 is one of
the commonest organisms responsible for diarrhoeal outbreaks (16). An
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outbreak of O139 was also reported
in 2002 (5). However, data on the isolation rate and antibiotic susceptibility pattern of non-O1 and non-O139
V. cholerae are lacking. Such data are
valuable for the empirical treatment
of patients in special circumstances
and to compare with reports from
other countries. This study therefore
aimed to evaluate the frequency and
antimicrobial profile of non-O1 and
non-O139 V. cholerae in Pakistan
from stool samples over the years
1999–2012.

Method
Study design and setting

This was a retrospective analysis of
antimicrobial resistance among nonO1 and non-O139 V. cholerae strains
isolated at the clinical microbiology
laboratory of Aga Khan University hospital in Karachi, Pakistan, for diagnostic
purposes. This laboratory caters for
inpatients as well as outside referrals
from other hospitals, clinics and general practitioners across the country.
All 95 800 stool samples submitted
to the laboratory for analysis from the
years 1999 to 2012 were included in
the study.
The study protocol and consent
procedures were approved by the ethics review committee of the Aga Khan
University Hospital. Specific verbal or
written consent from patients was not
required as the data used were obtained
from laboratory records and used
anonymously.
Data collection

All stool samples for culture were processed according to standard practice
and were inoculated on the following
media: MacConkey, SalmonellaShigella, Campylobacter and tellurite
taurocholate gelatin agar (TTGA)
(Oxoid). Stool samples were also inoculated in selenite F broth and alkaline-peptone water and sub-cultured

on solid media after overnight incubation. Suspected colonies from TTGA
were biochemically confirmed using
analytical profile index 20 Enterobacteriaceae (API 20 E) (BioMerieux).
V. cholerae O1 serogroups were
performed using polyvalent O1 antisera, for Ogawa and Inaba strains
(Murex Diagnostic) and serogroup
O139 (Dienka Sieken). Non-O1 and
non-O139 V. cholerae were reported
when an isolate had a biochemical
profile (using API 20 E) of V. cholerae
but failed to agglutinate by V. cholerae
antisera O1 and O139.
Antimicrobial drug susceptibility
assay was performed by the disk diffusion method using commercially available disks (Becton Dickinson; Sparks
Glencoe). The antibiotics tested were:
ampicillin (10 µg), tetracycline (30 µg),
co-trimoxazole (1.25/23.75 µg), chloramphenicol (30 µg) and ofloxacin (5
µg). Since there were no interpretive
breakpoints for V. cholerae available in
the Clinical and Laboratory Standard
Institute guidelines, breakpoints for
Enterobacteriaceae were adopted for
V. cholerae (17). Escherichia coli (ATCC
25922) strain was used as a quality control.
Data management and
statistical analysis

Data extracted from the computerized information system of the hospital were transferred to the statistical
software SPSS, version 19.0. Frequencies with percentages for age, seasonal
distribution and isolation rate were
analysed. The resistance pattern of
non-O1 and non-O139 V. cholerae
was evaluated among different age
groups.

Results
During the study period (1999–2012),
a total of 95 800 stool samples for
culture and susceptibility testing were
processed at the Aga Khan University
143
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Hospital laboratory. The yield of
positive samples (isolation of at least
1 diarrhoea-causing bacterial pathogen
including Salmonella spp., Shigella spp.,
V. cholerae, Campylobacter spp. and
Aeromonas spp.) was 20 125 (21%).
Out of these positive cultures 3668
isolates (18%) were V. cholerae group
(Table 1). Throughout the study
period (1999–2012) V. cholerae O1
serogroups remained the predominant
strain but a changing trend from serotype Ogawa to Inaba was seen in the
years 2005–6 and 2012 respectively
and again from Inaba to Ogawa was
seen in 2007 (Table 1). V. cholerae
O139 serogroup emerged only in the
years 2000–2002.
Of the total V. cholerae isolates, 233
(6%) failed to show agglutination by
O1 (Ogawa, Inaba) and O139 antisera. These isolates were confirmed as
V. cholerae by API 20E, and reported
as non-O1 and non-O139 V. cholerae. Table 1 shows the annual rate of
isolation of non-O1 and non-O139

V. cholerae over the study period; the
highest number of cases were seen in
the year 2003.
The majority of stool cultures yielding non-O1 and non-O139 V. cholerae
(98%) were submitted from different
locations of Karachi city. From other
locations 1% were isolated from Hyderabad and 0.7% and 0.3% were from
Mir Pur Khas and Jacobad respectively. Demographic data showed that
122 cases (52%) of non-O1 and nonO139 V. cholerae were in children aged
≤ 14 years and 111 (48%) in those
aged > 14 years old, and more cases
were in males (135, 58%) than females
(98, 42%). Seasonal variations in isolation frequency were observed, with
the few or no isolates during winter
and a maximum rate during summer
with peaks from May to August each
year (Figure 1).
The annual trend of antimicrobial
susceptibility data revealed increasing
resistance to antibiotics such as cotrimoxazole and ampicillin. The lowest

rate of resistance was observed against
ofloxacin, followed by tetracycline
and chloramphenicol, as shown in
Figure 2. Table 2 shows that for most
antibiotics antimicrobial resistance
rates were similar between children
and older age groups, except for cotrimoxazole which showed higher
resistance among children aged ≤ 14
years than adolescent/adults aged >
14 years (52% versus 33%).

Discussion
To the best of our knowledge this is
the first study reporting the frequency
of non-O1 and non-O139 V. cholerae from clinical samples tested at
a diagnostic laboratory of Pakistan.
We found that the rate of non-O1
and non-O139 V. cholerae remained
at a low level (≤ 10%) of the total V.
cholerae group throughout the study
period except from 2002 to 2004
where an upsurge was observed from
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Table 1 Annual isolation rate of non-O1and non-O139 Vibrio cholerae at Aga Khan University clinical laboratory; 1999–2012
Year of culture
testing

Stool
culture
performed

Stool
culture
growing
diarrhoeal
pathogens

V. cholerae
among
diarrhoeal
pathogens

V. cholerae strains
O1
(Ogawa)

O1
(Inaba)

O139

No.

No.

No.

No.

No.

No.

No.

%

841

317

282

31

0

4

1

Non-O1
and
non-O139

1999

4 807

2000

4 806

735

271

213

1

39

18

7

2001

5 587

1 108

412

325

2

81

4

1

2002

8 062

1 334

229

142

3

55

29

13

2003

9 943

2 063

262

182

9

2

69

27

2004

4 700

851

98

64

19

1

14

14

2005

5 556

2 473

738

2

721

0

15

2

2006

6 103

1 441

188

0

181

0

7

4

2007

6 365

1 084

286

149

122

0

15

5

2008

8 267

1 884

238

219

3

0

16

7

2009

9 999

2 667

248

223

5

0

20

8

2010

7 224

1 343

155

143

3

0

9

6

2011

7 597

1 294

152

136

10

0

6

4

2012

6 784

1 007

74

15

52

0

7

10

Total

95 800

20 124

3668

2095

1162

178

233

6

13% to 27%, with a prominent surge
in the year 2003.
Our findings of a low isolation rate
of non-O1 and non-O139 V. cholerae from clinical samples (overall 6%
of total V. cholerae) is consistent with
the sporadic form of diarrhoea caused
by endemic strains of non-O1 and nonO139 V. cholerae reported from other
countries in the region. A literature
search showed Indian studies reporting variable isolation frequencies of
non-O1 and non-O139 V. cholerae
from clinical samples. For example, 4%
and 5% isolation rates of non-O1 and
non-O139 V. cholerae were reported
from Sevagram in Maharashtra state
and Delhi respectively (18,19), and
higher isolation rates of 13% and 24%

from Kolkata and Hubli respectively
(17,20). Similarly, reports from Thailand showed a lower rate of up to 3%
of non-O1 and non-O139 V. cholerae
among V. cholerae isolates (21).
The increase in frequency of nonO1 and non-O139 V. cholerae noted
in 2003 is suggestive of a possible
outbreak in that year. Non-O1 and
non-O139 V. cholerae strains detected
during that period also had unique
features of co-trimoxazole resistance
of 100% compared with a baseline of
35–40% (Figure 2). A plausible association of this high isolation rate could
be related to heavy rainfalls leading to
nationwide flooding in 2003. These
findings are suggestive of a possible
emergence of a novel strain with a

unique antibiogram, and perhaps
increased pathogenicity, leading to
symptomatic disease. Due to the retrospective nature of the study we were
not been able to perform molecular
strain typing and could not retrieve
clinical data to confirm the outbreak
situation with the novel strain.
Interestingly a majority of non-O1
and non-O139 V. cholerae strains were
isolated from stool samples received
from Karachi, a coastal city which has
a questionable supply of clean drinking water and high rates of enteric
fever and other gastrointestinal infections in the community (22,23).
Additionally a lack of proper surveillance of diarrhoeal outbreaks leads
to paucity of data. Similar upsurges

Table 2 Frequency of non-O1 and non-O139 Vibrio cholerae isolation and antimicrobial resistance rates, by age group
Age (years)

Isolation
frequency

Antimicrobial resistance
Co-trimoxazole

Ampicillin

Tetracycline

No.

No.

%

No

%

No

%

≤ 14

122

63

52

12

10

1

1

> 14

111

37

33

13

12

4

4

Chloramphenicol
No

Ofloxacin

%

No

%

4

3

0

0

0

0

1

1
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100

Ampicillin

Proportion of resistance (%)
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Ofloxacin
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Figure 2 Annual antimicrobial resistance pattern of non-O1 and non-O139 Vibrio cholerae from 1999–2012

in the isolation rate of non-O1 and
non-O139 V. cholerae have been reported from India during the period
2002–04, showing replacement of
predominant V. cholerae O1 serotypes
(20). These findings suggest the possibility of a regional outbreak with
novel serotypes and emphasizes the
need for continuous surveillance and
monitoring of regional diarrhoeal
strains.
Throughout the duration of
the current study (1999–2012) V.
cholerae O1 serogroups remained
the predominant serotype. Another
interesting finding of our study is related to V. cholerae O139. It seems
that a new serotype with a different
antibiogram (5) had emerged in the
year 2000–02. This is comparable
with the similar trend reported from
India (19). Further comparison of
previously published antimicrobial
susceptibility data of V. cholerae O139
from Pakistan (5) is comparable with
India ( 19 ) and strains from both
regions had a similar susceptibility pattern to reported antimicrobials including co-trimoxazole (5,19).
146

This again highlights the likelihood
of circulation of particular type of V.
cholerae O139 in the Indian subcontinent during that period. Non-O1 and
non-O139 V. cholerae were likely to be
the origin of the new virulence gene,
as emergence of the O139 serovar
resulted due to horizontal gene transfer between V. cholerae O1 and O22
(24,25). Therefore, continuous monitoring of these serovars will provide
valuable information on mechanisms
of virulence.
Finally, the current data showed
a fluctuating pattern of susceptibility from year to year of non-O1 and
non-O139 V. cholerae isolates to the
antibiotics commonly used against
cholera. Low resistance to tetracycline was seen except in the year
2012. Resistance to co-trimoxazole
peaked in 2003 and 2012. Therefore
with empirical use of World Health
Organization recommended drugs
such as tetracycline and doxycycline
intended for treatment of cholera,
continuous monitoring of antimicrobial resistance surveillance should be
maintained.

Conclusion
In conclusion, this study found that,
despite annual fluctuations, the rate of
non-O1 and non-O139 V. cholerae remained a significant cause of diarrhoeal
illness in Pakistan, as it is in neighbouring regions, with the possibility of
emergence of novel pathogenic strains.
These findings emphasize the need for
continuous surveillance of serotypes
and monitoring of antimicrobial resistance of regional diarrhoeal strains to
predict future epidemics and define
measures to curtail the disease. Surveillance data will also provide baseline
information to develop empirical antibiotic choice, effective vaccines and
preventive strategies.
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